Disposition of 2181 shares by Scott Smith of BioatlaInc at 2.26 subject to Rule 16b-3
| BCAB Stock | USD 0.47 0.01 2.17% |
About 59% of Bioatla's investor base is looking to short. The analysis of the overall investor sentiment regarding Bioatla suggests that many traders are alarmed. The current market sentiment, together with Bioatla's historical and current headlines, can help investors time the market. In addition, many technical investors use Bioatla stock news signals to limit their universe of possible portfolio assets.
Bioatla |
Filed transaction by BioatlaInc Director. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
Read at macroaxis.com
Bioatla Fundamental Analysis
We analyze Bioatla's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Bioatla using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Bioatla based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Return On Equity
Return On Equity Comparative Analysis
Bioatla is currently under evaluation in return on equity category among its peers. Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Bioatla Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Bioatla stock to make a market-neutral strategy. Peer analysis of Bioatla could also be used in its relative valuation, which is a method of valuing Bioatla by comparing valuation metrics with similar companies.
Peers
Bioatla Related Equities
| ACRV | Acrivon Therapeutics, | 4.84 | ||||
| GLUE | Monte Rosa | 3.26 | ||||
| ADAG | Adagene | 2.70 | ||||
| AVTE | Aerovate Therapeutics | 1.55 | ||||
| RZLT | Rezolute | 0.77 | ||||
| ERAS | Erasca | 0.53 | ||||
| IKNA | Ikena Oncology | 0.67 | ||||
| PMVP | Pmv Pharmaceuticals | 1.39 | ||||
| NRIX | Nurix Therapeutics | 1.55 | ||||
| KYMR | Kymera Therapeutics | 2.13 | ||||
| DSGN | Design Therapeutics | 2.41 | ||||
| ANTX | AN2 Therapeutics | 2.56 | ||||
| NAUT | Nautilus Biotechnology | 3.39 | ||||
| FHTX | Foghorn Therapeutics | 3.46 | ||||
| OLMA | Olema Pharmaceuticals | 3.48 | ||||
| IPSC | Century Therapeutics | 3.53 | ||||
| PASG | Passage Bio | 4.92 | ||||
| CCCC | C4 Therapeutics | 5.71 | ||||
| STTK | Shattuck Labs | 7.20 |
Complementary Tools for Bioatla Stock analysis
When running Bioatla's price analysis, check to measure Bioatla's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bioatla is operating at the current time. Most of Bioatla's value examination focuses on studying past and present price action to predict the probability of Bioatla's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bioatla's price. Additionally, you may evaluate how the addition of Bioatla to your portfolios can decrease your overall portfolio volatility.
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk |